Tag:
QAB149
Latest Headlines
Latest Headlines
Novartis hit with FDA delay on blockbuster COPD drug
Novartis is facing what could be a serious setback on one of its most promising drug candidates. The FDA said today that it will need to see more information on dosing before it can approve
Novartis gets blockbuster late-stage data in COPD trial
One of Novartis' would-be blockbusters generated promising late-stage data as a therapy for chronic obstructive pulmonary disease. Compared with a standard treatment option for COPD, QAB149
